Evidence map›Paper›PMID 14977971›Full record

ArticleInfection and immunity2004

Blockade of endogenous leukotrienes exacerbates pulmonary histoplasmosis.

Alexandra I Medeiros, Anderson Sá-Nunes, Edson G Soares, Camila M Peres, Célio L Silva, Lúcia H Faccioli

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 120 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Leukotrienes in Innate Immunity: Still Underappreciated after All These Years?Journal of immunology (Baltimore, Md. : 1950) · 2023
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Prostaglandins DJournal of lipid research · 2018
    Article
  14. Leukotriene BScientific reports · 2017
    Article
  15. Host-Derived Leukotriene BFrontiers in immunology · 2017
    Article
  16. Article
  17. TGF-β/SMAD Pathway and Its Regulation in Hepatic Fibrosis.The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2016
    Review
  18. Article
  19. Protective Effect of Galectin-1 duringMediators of inflammation · 2016
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alexandra I MedeirosDepartamento de Análises Clínicas, Toxicológicas e Bromatológicas, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo 14040-903, Brazil.
Anderson Sá-Nunes
Edson G Soares
Camila M Peres
Célio L Silva
Lúcia H Faccioli
SUPERA Park of Innovation and Technology of Ribeirão Preto · BRUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leukotrienes are classical mediators of inflammatory response. New aspects of leukotriene function have recently been described. We examine here the previously unreported role that leukotrienes play in the regulation of cytokines in a murine model of histoplasmosis. We demonstrate that administration of MK 886, a leukotriene synthesis inhibitor, caused Histoplasma capsulatum-infected mice to die by the day 15 of infection, whereas the correlating death rate in untreated infected mice was 0%. Treating infected animals with MK 886 inhibited leukotriene synthesis but increased leukocyte recruitment to the lungs. Subsequent to this phenomenon, levels of tumor necrosis factor alpha, interleukin-1 (IL-1), IL-6, and KC chemoattractant cytokines and fungi in the lung parenchyma increased, as did inflammatory response. In contrast, IL-2, IL-5, IL-12, and gamma interferon cytokine levels actually decreased. Thus, murine response to pulmonary histoplasmosis may be leukotriene modulated. This finding may enable us to alter the course of the immune response and inflammation caused by histoplasmosis. The data from the present study suggest an important new strategy for immunologic or drug intervention in human patients.

Indexed as

AnimalsBronchoalveolar Lavage FluidChlorobenzenesCytokinesDisease Models, AnimalHistoplasmaHistoplasmosisHumansIndolesIn Vitro TechniquesLeukocytesLeukotrienesLipoxygenase InhibitorsLung Diseases, FungalMaleMiceChlorobenzenesCytokinesIndolesLeukotrienesLipoxygenase InhibitorsMK-886Nitric Oxide

Identifiers

PMID14977971
PMCPMC355884
OpenAlexW2166959863

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.